Work

Tu1791 UPADACITINIB IS EFFECTIVE AND SAFE IN TOFACITINIB-EXPERIENCED PATIENTS WITH ULCERATIVE COLITIS: A PROSPECTIVE REAL-WORLD EXPERIENCE